VP
venBio Partners’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.03M | Hold |
9,699,925
| – | – | 3.51% | 5 |
|
|
2025
Q1 | $6.04M | Hold |
9,699,925
| – | – | 4.89% | 5 |
|
|
2024
Q4 | $16.2M | Hold |
9,699,925
| – | – | 9.49% | 4 |
|
|
2024
Q3 | $17.7M | Hold |
9,699,925
| – | – | 9.08% | 6 |
|
|
2024
Q2 | $58.5M | Hold |
9,699,925
| – | – | 25.26% | 2 |
|
|
2024
Q1 | $108M | Hold |
9,699,925
| – | – | 38.37% | 1 |
|
|
2023
Q4 | $144M | Hold |
9,699,925
| – | – | 21.65% | 2 |
|
|
2023
Q3 | $46.6M | Hold |
9,699,925
| – | – | 13.2% | 3 |
|
|
2023
Q2 | $72.8M | Hold |
9,699,925
| – | – | 26.36% | 2 |
|
|
2023
Q1 | $43.8M | Hold |
9,699,925
| – | – | 24.3% | 2 |
|
|
2022
Q4 | $109M | Hold |
9,699,925
| – | – | 33.89% | 2 |
|
|
2022
Q3 | $92.8M | Hold |
9,699,925
| – | – | 21.48% | 2 |
|
|
2022
Q2 | $78.5M | Hold |
9,699,925
| – | – | 22.34% | 1 |
|
|
2022
Q1 | $164M | Hold |
9,699,925
| – | – | 36.34% | 1 |
|
|
2021
Q4 | $208M | Hold |
9,699,925
| – | – | 37.55% | 1 |
|
|
2021
Q3 | $716M | Hold |
9,699,925
| – | – | 71.37% | 1 |
|
|
2021
Q2 | $530M | Hold |
9,699,925
| – | – | 62.6% | 1 |
|
|
2021
Q1 | $715M | Hold |
9,699,925
| – | – | 67.97% | 1 |
|
|
2020
Q4 | $836M | Hold |
9,699,925
| – | – | 73.8% | 1 |
|
|
2020
Q3 | $366M | Buy |
+9,699,925
| New | +$366M | 55.63% | 1 |
|